What apps should you recommend to patients who are in physical therapy? Here are highlights of 5 physical therapy apps to consider.
Arcutis Announces Positive Phase 3 Data on Roflumilast Cream 0.05% for Atopic Dermatitis in Young Children
Investigators reported that roflumilast cream 0.05% significantly reduced AD severity as early as Week 1, with a notable effect on pruritus seen in as little as 24 hours.
Primary Viewpoints: Immunizations with Dr Steven P. Furr
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.
FDA Approves Expanded Use for Sublocade for Opioid Use Disorder
These label changes to Sublocade from Indivior mark a significant advancement in the management of moderate to severe opioid use disorder.
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
Depression Increases Risk For and Accrual of Long-Term Health Disorders
Comorbid conditions accrued at a rate 30% faster among adults with depression than in those without the disorder over a 7-year follow-up period.
Dupilumab Cardiometabolic Safety in Real-World Study of Atopic Dermatitis Supports Clinical Trial Evidence
Treatment of AD with dupilumab, compared with cyclosporine and methotrexate, was associated with significantly reduced risk of a wide range of CV outcomes at 1 year.